B

Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613

Watchlist Manager
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Watchlist
Price: 7.85 HKD -2.48% Market Closed
Market Cap: 6.6B HKD
Have any thoughts about
Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Beijing Tong Ren Tang Chinese Medicine Co Ltd

Wall Street analysts forecast Beijing Tong Ren Tang Chinese Medicine Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 12.29 HKD with a low forecast of 11.41 HKD and a high forecast of 13.44 HKD.

Lowest
Price Target
11.41 HKD
45% Upside
Average
Price Target
12.29 HKD
57% Upside
Highest
Price Target
13.44 HKD
71% Upside
Beijing Tong Ren Tang Chinese Medicine Co Ltd Competitors:
Price Targets
IMP
Imexpharm Corp
2% Upside
1177
Sino Biopharmaceutical Ltd
42% Upside
ERIS
Eris Lifesciences Ltd
12% Upside
000513
Livzon Pharmaceutical Group Inc
9% Upside
002262
Jiangsu Nhwa Pharmaceutical Co Ltd
26% Upside
688166
BrightGene Bio-Medical Technology Co Ltd
49% Upside
600079
Humanwell Healthcare Group Co Ltd
12% Upside
GLS
Glenmark Life Sciences Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
Beijing Tong Ren Tang Chinese Medicine Co Ltd

For the last 8 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is 10%.

6%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Beijing Tong Ren Tang Chinese Medicine Co Ltd

For the last 8 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's operating income is 4%. The projected CAGR for the next 3 years is 16%.

4%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Beijing Tong Ren Tang Chinese Medicine Co Ltd

For the last 8 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's net income is 5%. The projected CAGR for the next 3 years is 12%.

5%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's stock price target?
Price Target
12.29 HKD

According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 12.29 HKD with a low forecast of 11.41 HKD and a high forecast of 13.44 HKD.

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is 10%.

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's operating income is 4%. The projected CAGR for the next 3 years is 16%.

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Net Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's net income is 5%. The projected CAGR for the next 3 years is 12%.

Back to Top